Cargando…

Schizophrenia and depression, two poles of endocannabinoid system deregulation

The activity of certain G protein-coupled receptors (GPCRs) and of glutamate N-Methyl-D-aspartate receptors (NMDARs) is altered in both schizophrenia and depression. Using postmortem prefrontal cortex samples from subjects with schizophrenia or depression, we observed a series of opposite changes in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rodríguez-Muñoz, María, Sánchez-Blázquez, Pilar, Callado, Luis F., Meana, J. Javier, Garzón-Niño, Javier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802629/ https://www.ncbi.nlm.nih.gov/pubmed/29249810 http://dx.doi.org/10.1038/s41398-017-0029-y

Ejemplares similares

Endocannabinoid control of glutamate NMDA receptors: the therapeutic potential and consequences of dysfunction
por: Rodríguez-Muñoz, María, et al.
Publicado: (2016)

The cannabinoid receptor 1 associates with NMDA receptors to produce glutamatergic hypofunction: implications in psychosis and schizophrenia
por: Sánchez-Blázquez, Pilar, et al.
Publicado: (2014)

Increased PKC activity and altered GSK3β/NMDAR function drive behavior cycling in HINT1-deficient mice: bipolarity or opposing forces
por: Garzón-Niño, Javier, et al.
Publicado: (2017)

The ALS-Related σ1R E102Q Mutant Eludes Ligand Control and Exhibits Anomalous Response to Calcium
por: Rodríguez-Muñoz, María, et al.
Publicado: (2020)

(α)N-Acetyl β-Endorphin Is an Endogenous Ligand of σ1Rs That Regulates Mu-Opioid Receptor Signaling by Exchanging G Proteins for σ2Rs in σ1R Oligomers
por: Garzón-Niño, Javier, et al.
Publicado: (2022)

Sigma 1 Receptor Antagonists Inhibit Manic-Like Behaviors in Two Congenital Strains of Mice
por: Sánchez-Blázquez, Pilar, et al.
Publicado: (2018)

The Sigma 2 receptor promotes and the Sigma 1 receptor inhibits mu-opioid receptor-mediated antinociception
por: Sánchez-Blázquez, Pilar, et al.
Publicado: (2020)

The σ1 Receptor and the HINT1 Protein Control α2δ1 Binding to Glutamate NMDA Receptors: Implications in Neuropathic Pain
por: Rodríguez-Muñoz, María, et al.
Publicado: (2021)

Characterization of dopamine D(2) receptor coupling to G proteins in postmortem brain of subjects with schizophrenia
por: Egusquiza, Iker, et al.
Publicado: (2021)

Mu-Opioid Receptors Transiently Activate the Akt-nNOS Pathway to Produce Sustained Potentiation of PKC-Mediated NMDAR-CaMKII Signaling
por: Sánchez-Blázquez, Pilar, et al.
Publicado: (2010)

Fenfluramine diminishes NMDA receptor-mediated seizures via its mixed activity at serotonin 5HT2A and type 1 sigma receptors
por: Rodríguez-Muñoz, María, et al.
Publicado: (2018)

The ON:OFF switch, σ1R-HINT1 protein, controls GPCR-NMDA receptor cross-regulation: Implications in neurological disorders
por: Rodríguez-Muñoz, María, et al.
Publicado: (2015)

Ribosomal Protein S6 Hypofunction in Postmortem Human Brain Links mTORC1-Dependent Signaling and Schizophrenia
por: Ibarra-Lecue, Inés, et al.
Publicado: (2020)

Endocannabinoids and Schizophrenia
por: Desfossés, Joëlle, et al.
Publicado: (2010)

S182. HISTONE H3 AND H4 POST-TRANSLATIONAL REGULATION IN SCHIZOPHRENIA POSTMORTEM BRAIN: EFFECT OF ANTIPSYCHOTIC TREATMENT
por: Martínez-Peula, Oihane, et al.
Publicado: (2020)

Group II Metabotropic Glutamate Receptors as Targets for Novel Antipsychotic Drugs
por: Muguruza, Carolina, et al.
Publicado: (2016)

Calcium-binding proteins are altered in the cerebellum in schizophrenia
por: Vidal-Domènech, Francisco, et al.
Publicado: (2020)

HINT1 protein cooperates with cannabinoid 1 receptor to negatively regulate glutamate NMDA receptor activity
por: Vicente-Sánchez, Ana, et al.
Publicado: (2013)

The Axonal Motor Neuropathy-Related HINT1 Protein Is a Zinc- and Calmodulin-Regulated Cysteine SUMO Protease
por: Cortés-Montero, Elsa, et al.
Publicado: (2019)

The Endocannabinoid/Endovanilloid System and Depression
por: Smaga, Irena, et al.
Publicado: (2014)

Calmodulin Supports TRPA1 Channel Association with Opioid Receptors and Glutamate NMDA Receptors in the Nervous Tissue
por: Cortés-Montero, Elsa, et al.
Publicado: (2020)

Intracellular inflammatory and antioxidant pathways in postmortem frontal cortex of subjects with major depression: effect of antidepressants
por: Martín-Hernández, David, et al.
Publicado: (2018)

Differential brain ADRA2A and ADRA2C gene expression and epigenetic regulation in schizophrenia. Effect of antipsychotic drug treatment
por: Brocos-Mosquera, Iria, et al.
Publicado: (2021)

Morphine induces endocytosis of neuronal μ-opioid receptors through the sustained transfer of Gα subunits to RGSZ2 proteins
por: Rodríguez-Muñoz, María, et al.
Publicado: (2007)

Cannabidiol enhances morphine antinociception, diminishes NMDA-mediated seizures and reduces stroke damage via the sigma 1 receptor
por: Rodríguez-Muñoz, María, et al.
Publicado: (2018)

Opposite alterations of 5HT(2A) receptor brain density in subjects with schizophrenia: relevance of radiotracers pharmacological profile
por: Diez-Alarcia, Rebeca, et al.
Publicado: (2021)

Cannabis use selectively modulates circulating biomarkers in the blood of schizophrenia patients
por: Ibarra‐Lecue, Inés, et al.
Publicado: (2022)

Endocannabinoid signalling in the blood of patients with schizophrenia
por: De Marchi, Nicola, et al.
Publicado: (2003)

Kynurenines and the Endocannabinoid System in Schizophrenia: Common Points and Potential Interactions
por: Zádor, Ferenc, et al.
Publicado: (2019)

Reviewing the Role of the Endocannabinoid System in the Pathophysiology of Depression
por: Gallego-Landin, Ines, et al.
Publicado: (2021)

Gz mediates the long-lasting desensitization of brain CB1 receptors and is essential for cross-tolerance with morphine
por: Garzón, Javier, et al.
Publicado: (2009)

A possible role for the endocannabinoid system in the neurobiology of depression
por: Serra, Gino, et al.
Publicado: (2007)

Changes in the Brain Endocannabinoid System in Rat Models of Depression
por: Smaga, Irena, et al.
Publicado: (2017)

Endocannabinoid System in the Neuroendocrine Response to Lipopolysaccharide-induced Immune Challenge
por: De Laurentiis, Andrea, et al.
Publicado: (2022)

The Sigma-1 Receptor Antagonist, S1RA, Reduces Stroke Damage, Ameliorates Post-Stroke Neurological Deficits and Suppresses the Overexpression of MMP-9
por: Sánchez-Blázquez, Pilar, et al.
Publicado: (2017)

Chronic cannabis promotes pro-hallucinogenic signaling of 5-HT2A receptors through Akt/mTOR pathway
por: Ibarra-Lecue, Inés, et al.
Publicado: (2018)

Endocannabinoid system: Role in depression, reward and pain control (Review)
por: Huang, Wen-Juan, et al.
Publicado: (2016)

Commonalities for comorbidity: Overlapping features of the endocannabinoid system in depression and epilepsy
por: Epps, S. Alisha
Publicado: (2022)

Endocannabinoid System and Exogenous Cannabinoids in Depression and Anxiety: A Review
por: Hasbi, Ahmed, et al.
Publicado: (2023)

Alterations of the endocannabinoid system and circulating and peripheral tissue levels of endocannabinoids in sarcopenic rats
por: Le Bacquer, Olivier, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_k3ckvs0g0r8ifk0hlfvppnt5bl